ALID Stock Performance, Insider Transaction and News

ALID - ALLIED CORP

Market Cap	24.26M	P/E	-	EPS this Y	-	Ern Qtrly Grth	-
Income	-7.73M	Forward P/E	-	EPS next Y	-	50D Avg Chg	5.00%
Sales	98.65k	PEG	-	EPS past 5Y	-	200D Avg Chg	1.00%
Dividend	N/A	Price/Book	N/A	EPS next 5Y	-	52W High Chg	-64.00%
Recommedations	-	Quick Ratio	0.03	Shares Outstanding	108.32M	52W Low Chg	145.00%
Insider Own	48.02%	ROA	-106.52%	Shares Float	72.26M	Beta	-0.59
Inst Own	0.00%	ROE	-	Shares Shorted/Prior	-/-	Price	0.25
Gross Margin	-	Profit Margin	-	Avg. Volume	7,485	Target Price	-
Oper. Margin	-920.24%	Earnings Date	-	Volume	2,600	Change	8.81%

Healthcare | Drug Manufacturers - Specialty & Generic | Canada

About ALLIED CORP

Allied Corp., a cannabis company, engages in the research, development, and production of cannabinoid health solutions in the United States. The company offers hemp derived CBD natural health products, including Liberty, a hemp-derived cannabidiol (CBD) tincture; Tactical Hydration, a CBD infused electrolyte replacement drink; FIZZ Tablets for adding in a water bottle; Battle Balm, a CBD roll on activity rub for aches and pains; and Quick Hit, a CBD gummies under the Tactical Relief brand. It also provides Hydrosport CBD Drink, a CBD infused electrolyte replacement drink with sodium citrate electrolyte replacement; Hydrosport Tincture, a CBD tincture fortified with specific terpene profile; FIZZ Tablets for adding to a water bottle; Sport Rub, a CBD post activity rub for aches and pains; and Quick Hit, a CBD gummies with vitamin B12 under the Equilibrium Bio brand. In addition, the company offers Skin Structure, a facial formula applied to enhance skin; Eye Recover that helps the eye skin ward off free radicals, as well as helping to protect against sun damage; Glossy Lip Recover, which moisturizes and nourishes lips; Skin Designer that stimulates cell regeneration while minimizing age spots; Vitamin Absolute, a moisturizing facial oil; and Absolute Recover, a formulation that allows the infused bioactive compounds for areas with inflammation, pain, and other skin ailments under the MaXXa brand. Further, it is developing ALID 10 and ALID 11, which is in Phase I clinical trial a pharma product for the treatment of post-traumatic stress disorder and related mental health conditions. The company is headquartered in Kelowna, Canada.

ALID Chatroom

SaccaSpuds Posted - 09/21/24

$ALID tick tick tick……mwah!

SaccaSpuds Posted - 06/21/24

$ALID tick tick tick boom!💥

SaccaSpuds Posted - 06/20/24

$ALID we have a nibble….

SaccaSpuds Posted - 5 months ago

$ALID let her rip….:

SaccaSpuds Posted - 7 months ago

$ALID soon $0.5

PawPawRicoSpeculator Posted - 7 months ago

$BBRRF $ALID

SaccaSpuds Posted - 7 months ago

$ALID about time for this to explode northwards to the $0.5 range….

SaccaSpuds Posted - 8 months ago

$CGC $CRON $ACB watch out for $ALID Lowest costs, highest yield and already exporting from Columbia….huge potential.

SaccaSpuds Posted - 8 months ago

$ALID just bought some more. Let’s get back to $1

PawPawRicoSpeculator Posted - 8 months ago

$ALID Nice….😊

SaccaSpuds Posted - 02/28/24

$ALID wow...this is depressing...

SaccaSpuds Posted - 02/21/24

$ALID another 52week low…..fml $ALID has been disastrous. I feel a bit A Lied to

PawPawRicoSpeculator Posted - 01/29/24

$ALID https://www.investorsobserver.com/news/qm-pr/7670756779456016

PawPawRicoSpeculator Posted - 01/29/24

$ALID We just signed a contract to supply the UK for 3 years.

SaccaSpuds Posted - 01/29/24

$MO $CRON $TLRY $ACB $ALID

SaccaSpuds Posted - 01/29/24

$ALID #ilikethestock #tothemoon #fuckthetutes

SaccaSpuds Posted - 01/29/24

$ALID Allied Signs a 3-Year Sales Agreement to Provide its Colombian Grown Cannabis to the United Kingdom

SaccaSpuds Posted - 01/29/24

$ALID $ACB $TLRY $CRON $MO Kelowna, BC, Canada – TheNewswire - January 29, 2024 - Allied Corp. ("Allied" or the “Company”) (OTC:ALID) is pleased to announce that it has signed a three-year sales and distribution agreement for the UK market. This comes following the expansion of Allied’s commercial team in 2023 and the recent announcement of strategic channel partnerships to enable EU-GMP manufactured products to be distributed across Europe. According to Prohibition Partner’s 2023 European Cannabis Report, the UK market is set to become the second largest medical cannabis market in Europe after Germany. “This achievement is the result of the company’s dedication to expanding its commercial efforts in 2023 and marks a significant milestone as we are set to enter one of the most promising European markets.” says Juba Hadid, VP of Global Sales.

SaccaSpuds Posted - 01/29/24

$ALID turning the corner?

SaccaSpuds Posted - 01/29/24

$ALID amazing news today

SaccaSpuds Posted - 01/22/24

$ALID hey Calum any interest in throwing your shareholders a bone here? No? I thought not….

SaccaSpuds Posted - 10 months ago

$ALID trash stock. CEO seems to have forgotten his shareholders.